Teva Pharmaceutical Industries (TEVA) Change in Acquisitions & Divestments (2009 - 2025)

Teva Pharmaceutical Industries (TEVA) has reported Change in Acquisitions & Divestments for 16 consecutive years, with $42.0 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $42.0 million; the trailing twelve-month figure through Dec 2025 stood at $82.0 million (up 105.0% YoY), and the FY2025 full-year result was $42.0 million, up 5.0% from the prior year.
• Change in Acquisitions & Divestments rose to $42.0 million in Q4 2025 per TEVA's latest filing, from $40.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $107.0 million in Q2 2021 and bottomed at $1.0 million in Q3 2022.
• Historically, Change in Acquisitions & Divestments has averaged $36.9 million across 4 years, with a median of $40.0 million in 2024.
• The sharpest annual moves came in 2021 and 2022: Change in Acquisitions & Divestments surged 3466.67% in 2021, then plunged 97.2% in 2022.
• Over 4 years, Change in Acquisitions & Divestments stood at $19.0 million in 2021, then sank by 94.74% to $1.0 million in 2022, then surged by 3900.0% to $40.0 million in 2024, then climbed by 5.0% to $42.0 million in 2025.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $42.0 million, $40.0 million, and $1.0 million for Q4 2025, Q3 2024, and Q3 2022 respectively.